ATE381318T1 - Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum - Google Patents

Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum

Info

Publication number
ATE381318T1
ATE381318T1 AT02796803T AT02796803T ATE381318T1 AT E381318 T1 ATE381318 T1 AT E381318T1 AT 02796803 T AT02796803 T AT 02796803T AT 02796803 T AT02796803 T AT 02796803T AT E381318 T1 ATE381318 T1 AT E381318T1
Authority
AT
Austria
Prior art keywords
porous support
supercritical
fluidum
production
supercritical fluid
Prior art date
Application number
AT02796803T
Other languages
English (en)
Inventor
Bernard Freiss
Florence Marciacq
Jacques Fages
Martial Sauceau
Hubert Lochard
Jean-Jacques Letourneau
Christophe Joussot-Dubien
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE381318T1 publication Critical patent/ATE381318T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02796803T 2001-10-12 2002-10-11 Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum ATE381318T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0113178A FR2830760B1 (fr) 2001-10-12 2001-10-12 Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique

Publications (1)

Publication Number Publication Date
ATE381318T1 true ATE381318T1 (de) 2008-01-15

Family

ID=8868228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02796803T ATE381318T1 (de) 2001-10-12 2002-10-11 Herstellungsverfahren einer interaktionverbindung von wirkstoffen mit einem porösen träger durch ein überkritisches fluidum

Country Status (17)

Country Link
US (1) US7390411B2 (de)
EP (1) EP1434567B1 (de)
JP (1) JP4401778B2 (de)
CN (1) CN100396277C (de)
AT (1) ATE381318T1 (de)
AU (1) AU2002361279B2 (de)
BR (2) BR0213220A (de)
CA (1) CA2462537C (de)
CY (1) CY1107306T1 (de)
DE (1) DE60224215T2 (de)
DK (1) DK1434567T3 (de)
ES (1) ES2295446T3 (de)
FR (1) FR2830760B1 (de)
MX (1) MXPA04003300A (de)
PT (1) PT1434567E (de)
WO (1) WO2003043604A1 (de)
ZA (1) ZA200402580B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854079B1 (fr) 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
FR2868315B1 (fr) * 2004-04-01 2006-07-14 Pierre Fabre Medicament Sa Procede de preparation d'un compose d'inclusion soluble de substances actives dans une molecule hote avec l'aide d'un agent d'interaction par fluide supercritique
RU2382654C2 (ru) * 2004-04-01 2010-02-27 Пьер Фабр Медикаман Комплексы включения, полученные способом с использованием co2 в сверхкритическом состоянии и агента взаимодействия с комплексом
FR2876914A1 (fr) * 2004-10-21 2006-04-28 Pierre Fabre Medicament Sa Complexe comprenant un antibiotique, une cyclodextrine et un agent d'interaction
FR2876910B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
ITSA20050008A1 (it) * 2005-03-10 2006-09-11 Univ Degli Studi Salerno Processo per la produzione di membrane caricate con uno o piu' principi attivi
DE602006013933D1 (de) * 2006-02-10 2010-06-10 Carotech Sdn Bhd Chemor Verfahren zur Gewinnung hochangereicherter Naturstoff-fraktionen aus Palmöl unter Verwendung von superkritischen und beinahe superkritischen Flüssigmedien
FR2944280B1 (fr) 2009-04-09 2012-08-03 Galderma Res & Dev Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines
FR2944207B1 (fr) * 2009-04-09 2011-05-06 Galderma Res & Dev Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations
PL2699114T3 (pl) * 2011-04-22 2018-11-30 Pepsico, Inc. Kapsułkowanie ekstraktu w porowatych cząstkach
EP2884523B1 (de) * 2013-12-16 2020-02-05 IMEC vzw Verfahren zum Aktivieren einer porösen Schichtoberfläche
CN105343893B (zh) * 2015-12-11 2018-07-20 中国药科大学 对乙酰氨基酚-2-羟丙基-β-环糊精包合物制备方法
KR102096724B1 (ko) * 2016-01-08 2020-04-03 아크로 바이오메디컬 컴퍼니 엘티디 무세포 각막, 무세포 각막의 제조 방법 및 그의 용도
CN116688155A (zh) * 2023-07-20 2023-09-05 内蒙古工业大学 一种木犀草素/γ-环糊精包合物、制备方法及应用
CN118697820A (zh) * 2024-05-31 2024-09-27 广州新征程生物科技有限公司 一种治疗心脑血管病的中药及制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US189454A (en) * 1877-04-10 Improvement in paper boxes
GB2191715B (en) 1986-06-17 1990-07-25 Midrex Int Bv Method and apparatus for dedusting and desulfurizing gases
JPH0677511B2 (ja) * 1986-12-05 1994-10-05 金印わさび株式会社 香辛成分の包接化合物の製造方法
US4822497A (en) * 1987-09-22 1989-04-18 Modar, Inc. Method for solids separation in a wet oxidation type process
DE3744329A1 (de) * 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
FR2629735B1 (fr) * 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
GB9100643D0 (en) 1991-01-11 1991-02-27 Shaffery Michael J Filter system
US5389263A (en) * 1992-05-20 1995-02-14 Phasex Corporation Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX
ATE166573T1 (de) * 1993-03-24 1998-06-15 Ciba Geigy Ag Verfahren zur herstellung einer liposomendispersion im hochdruckbereich
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
EP0706821A1 (de) 1994-10-06 1996-04-17 Centre De Microencapsulation Verfahren zum Beschichten von Partikeln
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
JP3986086B2 (ja) 1996-03-01 2007-10-03 ザ ユニバーシティ オブ カンザス 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
DE19711393C1 (de) 1997-03-19 1998-08-13 Fraunhofer Ges Forschung Verfahren zum Mikroverkapseln von Partikeln
IT1296464B1 (it) 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9810559D0 (en) 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
GB9824298D0 (en) 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
SE9804001D0 (sv) * 1998-11-23 1998-11-23 Astra Ab New process
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
CN1280875A (zh) * 1999-06-30 2001-01-24 刘士群 用超临界反萃剂制造微粒的方法和装置
FR2798863B1 (fr) * 1999-09-27 2001-12-28 Separex Sa Procede et installation de mise a l'etat adsorbe sur un support poreux de composes actifs contenus dans un produit
FR2799984B1 (fr) 1999-10-21 2002-05-03 Lavipharm Procede de fractionnement d'une matiere composee de plusieurs constituants a l'aide d'un solvant a pression supercritique
FR2803538B1 (fr) 1999-12-15 2002-06-07 Separex Sa Procede et dispositif de captage de fines particules par percolation dans un lit de granules
FR2815540B1 (fr) * 2000-10-19 2005-06-10 Separex Sa Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote
US6896905B2 (en) * 2001-02-15 2005-05-24 Rohm And Haas Company Porous particles, their aqueous dispersions, and method of preparation
WO2002089851A1 (fr) 2001-03-06 2002-11-14 Separex (Societe Anonyme) Procede de fabrication de complexes hote-client

Also Published As

Publication number Publication date
DK1434567T3 (da) 2008-05-05
FR2830760A1 (fr) 2003-04-18
JP4401778B2 (ja) 2010-01-20
FR2830760B1 (fr) 2004-06-04
HK1087019A1 (zh) 2006-10-06
CA2462537C (fr) 2011-06-21
AU2002361279B2 (en) 2007-02-08
JP2005512621A (ja) 2005-05-12
DE60224215D1 (de) 2008-01-31
PT1434567E (pt) 2008-02-08
CN100396277C (zh) 2008-06-25
BRPI0213220B1 (pt) 2018-09-18
DE60224215T2 (de) 2008-12-04
EP1434567B1 (de) 2007-12-19
US7390411B2 (en) 2008-06-24
MXPA04003300A (es) 2004-07-23
CY1107306T1 (el) 2012-11-21
US20050274671A1 (en) 2005-12-15
WO2003043604A1 (fr) 2003-05-30
EP1434567A1 (de) 2004-07-07
BR0213220A (pt) 2004-08-31
CN1713894A (zh) 2005-12-28
CA2462537A1 (fr) 2003-05-30
AU2002361279A1 (en) 2003-06-10
ZA200402580B (en) 2004-11-04
ES2295446T3 (es) 2008-04-16

Similar Documents

Publication Publication Date Title
CY1107306T1 (el) Μεθοδος παρασκευης μιας ενωσεως αλληλεπιδρασεως δραστικων ουσιων με ενα πορωδες υποστρωμα μεσω ενος υπερκρισιμου ρευστου
ATE295185T1 (de) Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff
US7314070B2 (en) Method and apparatus for gradient generation
Zhmud et al. Dynamic surface tension in concentrated solutions of C n E m surfactants: a comparison between the theory and experiment
EA200601702A1 (ru) Нанесение дисперсных частиц металла на подложки с использованием сверхкритических жидкостей
DE60013626D1 (de) Verfahren zum herstellen von kohlenwasserstoffbrennstoffzusammen- setzungen und wässigre brennstoffzusammensetzungen
ATE322919T1 (de) Vorrichtung zur aufbereitung einer medizinischen flüssigkeit
ATE331021T1 (de) Verfahren zur herstellung von nichtionischen tensidgranulaten
AR005576A1 (es) Un proceso para la produccion de una composicion o componente detergente, y dicha composicion o componente detergente.
Rozenski et al. Overview of in‐capillary enzymatic reactions using capillary electrophoresis
ATE327823T1 (de) Verfahren zur herstellung von kolloidalen partikeln, die in form von nanokapseln sind
WO2003030867A3 (fr) Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique
ATE368451T1 (de) Verfahren zum überziehen von feststoffteilchen
CN103374343A (zh) 调剖驱油用吸水膨胀材料及其生产方法
KR960701696A (ko) 탈인재 및 탈인방법(dephosphorizing material and dephosphorizing method)
RU2143552C1 (ru) Способ обработки призабойной зоны нагнетательных скважин
CN101514036A (zh) 一种去除水体中芳香类化合物的方法
DK1401404T3 (da) Fremgangsmåde til indkapsling af et aktivt stof
JPH04130629A (ja) エッチング液調合装置
CN109609292B (zh) 一种超高泡沫稳定型洗衣液
RU93037047A (ru) Способ получения концентрата буровых технологических жидкостей
RU2096590C1 (ru) Способ освоения скважины
Wang Normal-phase HPLC enantioseparation of novel chiral metal tetrahedrane-type clusters on an amylose-based chiral stationary phase
KR970013080A (ko) 불산(hf)용액을 사용한 습식세정시 파티를 감소방법
RU2203407C2 (ru) Жидкость для вторичного вскрытия пласта перфорацией

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1434567

Country of ref document: EP